Analysis of blood carnitine profile and SLC22A5 gene variants in 17 neonates with Primary carnitine deficiency.
10.3760/cma.j.cn511377-20220125-00065
- Author:
Weiting SONG
1
;
Sheng YE
;
Lizhu ZHENG
Author Information
1. Department of Genetics and Metabolism, Ningde Maternal and Child Health Care Hospital, Ningde, Fujian 352199, China. 718190094@qq.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Infant, Newborn;
Cardiomyopathies/diagnosis*;
Carnitine;
Hyperammonemia/diagnosis*;
Muscular Diseases/genetics*;
Solute Carrier Family 22 Member 5/genetics*
- From:
Chinese Journal of Medical Genetics
2023;40(2):161-165
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the blood free carnitine (C0) level and SLC22A5 gene variants in 17 neonates with Primary carnitine deficiency (PCD) and to determine its incidence in local area and explore the correlation between C0 level and genotype.
METHODS:148 043 newborns born in 9 counties (cities and districts) of Ningde city from September 2016 to June 2021 were selected as study subjects. Blood free carnitine and acyl carnitine of 148 043 neonates were analyzed. Variants of the SLC22A5 gene were screened in those with blood C0 < 10 µmol/L, or C0 between 10 ∼ 15 µmol/L. Correlation between the free carnitine level and genetic variants was analyzed.
RESULTS:In total 17 neonates were diagnosed with PCD, which yielded a prevalence of 1/8 707 in the region. Twelve variants of the SLC22A5 gene were identified, with the common ones including c.760C>T, c.1400C>G and c.51C>G. Compared with those carrying other variants of the gene, children carrying the c.760C>T variant had significantly lower C0 values (P < 0.01).
CONCLUSION:The prevalence of PCD is relatively high in Ningde area, and intervention measures should be taken to prevent and control the disease. The c. 760C>T variant is associated with lower level of C0, which can provide a clue for the diagnosis.
